AR074725A1 - Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19- dioxa-5,7,26-triaza-tetraciclo(19.3.1.1 (2,6).1 (8,12) heptacosa-1(25),2 (26),3,5,8,10,12 (27),16,21,23-decaeno - Google Patents

Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19- dioxa-5,7,26-triaza-tetraciclo(19.3.1.1 (2,6).1 (8,12) heptacosa-1(25),2 (26),3,5,8,10,12 (27),16,21,23-decaeno

Info

Publication number
AR074725A1
AR074725A1 ARP090104835A ARP090104835A AR074725A1 AR 074725 A1 AR074725 A1 AR 074725A1 AR P090104835 A ARP090104835 A AR P090104835A AR P090104835 A ARP090104835 A AR P090104835A AR 074725 A1 AR074725 A1 AR 074725A1
Authority
AR
Argentina
Prior art keywords
dioxa
salt
tetraciclo
heptacose
decaene
Prior art date
Application number
ARP090104835A
Other languages
English (en)
Original Assignee
S Bio Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S Bio Pte Ltd filed Critical S Bio Pte Ltd
Publication of AR074725A1 publication Critical patent/AR074725A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Ciertas sales de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa-5,7,26triaza-tetra-ciclo[19.3.1.1(2,6),1(8,12)]heptacosa-1(25),2(26),35,8,10,12,(27),16,21,23-decaeno (Compuesto 1) del cual se descubrió que tiene propiedades mejoradas. En particular, la a la sal de maleato de este compuesto. También a composiciones farmacéuticas que contienen esta sal y métodos de uso de la sal en el tratamiento de ciertas condiciones médicas. Reivindicación 6: Una sal de acuerdo con cualquiera de las reivindicaciones 1 a 4 caracterizada porque muestra por difracción de rayos X al menos dos picos en la escala 2theta seleccionados del grupo que consiste de 8,3°ñ0.5°, 8,8°ñ0,5°, 16,9°ñ0,5°, 17,5°ñ0,5°, 19.0°ñ0,5°, 21,3°ñ0,5°, 23,8°ñ0,5°, 25,3°ñ0,5°, 25,8°ñ0,5° y 26,8°ñ0,5°.
ARP090104835A 2008-12-11 2009-12-11 Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19- dioxa-5,7,26-triaza-tetraciclo(19.3.1.1 (2,6).1 (8,12) heptacosa-1(25),2 (26),3,5,8,10,12 (27),16,21,23-decaeno AR074725A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12167608P 2008-12-11 2008-12-11

Publications (1)

Publication Number Publication Date
AR074725A1 true AR074725A1 (es) 2011-02-09

Family

ID=42103945

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP090104835A AR074725A1 (es) 2008-12-11 2009-12-11 Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19- dioxa-5,7,26-triaza-tetraciclo(19.3.1.1 (2,6).1 (8,12) heptacosa-1(25),2 (26),3,5,8,10,12 (27),16,21,23-decaeno
ARP190100702A AR114134A2 (es) 2008-12-11 2019-03-20 Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa-5,7,26-triaza-tetraciclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaeno

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP190100702A AR114134A2 (es) 2008-12-11 2019-03-20 Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa-5,7,26-triaza-tetraciclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaeno

Country Status (10)

Country Link
US (1) US8987243B2 (es)
EP (1) EP2376500B1 (es)
AR (2) AR074725A1 (es)
DK (1) DK2376500T3 (es)
ES (1) ES2536276T3 (es)
HR (1) HRP20150413T8 (es)
PL (1) PL2376500T3 (es)
PT (1) PT2376500E (es)
TW (1) TWI457342B (es)
WO (1) WO2010068182A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133900B2 (en) 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
US8604042B2 (en) 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
BR122021011788B1 (pt) 2005-11-01 2022-01-25 Impact Biomedicines, Inc Inibidores de biaril meta pirimidina de cinases, composição farmacêutica e processo para preparar uma composição farmacêutica
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI525096B (zh) * 2005-11-16 2016-03-11 Ｃｔｉ生技製藥有限公司 氧連接之嘧啶衍生物
AU2009325147B2 (en) * 2008-12-11 2014-08-14 Cti Biopharma Corp. 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt

Also Published As

Publication number Publication date
US20110263616A1 (en) 2011-10-27
WO2010068182A1 (en) 2010-06-17
PT2376500E (pt) 2015-06-02
TW201028425A (en) 2010-08-01
TWI457342B (zh) 2014-10-21
DK2376500T3 (en) 2015-05-04
AR114134A2 (es) 2020-07-22
PL2376500T3 (pl) 2015-07-31
US8987243B2 (en) 2015-03-24
HRP20150413T1 (hr) 2015-07-03
ES2536276T3 (es) 2015-05-22
EP2376500B1 (en) 2015-02-25
HRP20150413T8 (en) 2015-08-14
EP2376500A1 (en) 2011-10-19

Similar Documents

Publication Publication Date Title
CY1120031T1 (el) Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης
UY29469A1 (es) Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos.
CO6331340A2 (es) Pirrolo-pirimidinas y pirrolo piridinas
CO6640247A2 (es) Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo
DOP2011000198A (es) Compuestos y metodos de uso
EA201170772A1 (ru) Органические соединения
MX2011012122A (es) Derivados de tiofeno.
AR050717A1 (es) Composiciones farmaceuticas
BR112015019590A2 (pt) derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv
UY29343A1 (es) Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso.
CU20100032A7 (es) Depsipéptidos cíclicos
MX339644B (es) Sales de xantilio 3,6-disustituidas.
CL2008000629A1 (es) Compuestos macrociclicos derivados de 6-aril-4-mercapto-[1.3.5]triazina/[1.3]pirimidin-2-amina; composicion farmaceutica, utiles en el tratamiento del cancer.
AR114134A2 (es) Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa-5,7,26-triaza-tetraciclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaeno
BR112015026840A2 (pt) composto, sal farmaceuticamente aceitável, composição farmacêutica, uso de um composto, e, método prevenir ou tratar hiperfosfatemia
AR114133A2 (es) Sal de citrato de 11-(2-pirrolidin-1-il-etoxi)-14,19-dioxa-5,7,26-triaza-tetraciclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaeno
UA107455C2 (uk) Похідні індолу як протиракові агенти
CR20120146A (es) Derivados de espirolactama y usos de los mismos
ECSP11010856A (es) Composición farmacéutica sólida
CO6400138A2 (es) Compuesto anticancerígeno y composición farmacéutica que lo contiene
CY1111129T1 (el) Στερεη φαρμακευτικη ενωση που περιεχει τελιθρομυκινη
SMT201300112B (it) Sale citrato di 9E-15-(2-pirrolidin-1-il-etossi)-7,12,25-triossa-19,21,24-triaza-tetracicloÄ18.3.1.1(2,5).1(14,18)Üesacos a-1(24),2,4,9,14,16,18(26),20,22-nonaene
CY1112501T1 (el) Φαρμακευτικες συνθεσεις περιεχουσες λεφλουνομιδη
CY1117873T1 (el) ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ (1r,4r)-6’-ΦΘΟΡΟ-(Ν,Ν-ΔΙΜΕΘΥΛΟ)-4-ΦΑΙΝΥΛΟ-4΄, 9΄-ΔΙΥΔΡΟ-3’Η-ΣΠΕΙΡΟ-[ΚΥΚΛΟΕΞΑΝΟ-1,1 '-ΠΥΡΑΝΟ-[3,4,b]ΙΝΔΟΛ]-4-ΑΜΙΝΗΣ ΚΑΙ ΘΕΙΙΚΟΥ ΟΞΕΟΣ
GT200600132A (es) Una oxindoloxazolidinona como agente antibacteriano

Legal Events

Date Code Title Description
FG Grant, registration
FC Refusal